Revolution Medicines, Inc. (RVMD) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 15.14B |
| Enterprise Value | 14.92B |
| P/E Ratio | -23.32 |
| PEG Ratio | 0.48 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 21.9 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -26.73 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.61 |
| Return On Equity | -0.83 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -16.56M |
| EBITDA | -1.09B |
| Net Income | -1.13B |
| Diluted EPS | -5.95 |
| Total Cash | 1.91B |
| Total Cash/Share | 9.63 |
| Total Debt | 437.27M |
| Total Debt/Equity | 0.29 |
| Current Ratio | 6.8 |
| Book Value Per Share | 7.57 |
| 52-Week Change | 314.11 |
| 52-Week High | 166.84 |
| 52-Week Low | 34 |
| Moving Average 50 Days | 147.89 |
| Moving Average 200 Days | 95.81 |
| Average Volume | 3.18M |
| Shares Outstanding | 212.6M |
| % Held by Institutions | 104.29 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |